VHL and nonpapillary renal cell carcinoma: Biallelic loss or inactivation of the von Hippel Lindau (VHL) gene via mutation, deletion or promoter methylation occurs in up to 91 % of sporadic ccRCC [2] and drives a strong pro-survival and angiogenic program due to downstream hypoxia-inducible factor (HIF) accumulation [3].